Hvivo (HVO)

Sector:

Health Care

Index:

FTSE AIM All-Share

28.50p
   
  • Change Today:
      0.60p
  • 52 Week High: 30.60p
  • 52 Week Low: 18.00p
  • Currency: UK Pounds
  • Shares Issued: 680.37m
  • Volume: 1,724,303
  • Market Cap: £193.91m

Open Orphan launches Covid antibody testing service

By Josh White

Date: Thursday 04 Jun 2020

LONDON (ShareCast) - (Sharecast News) - Contract research organisation Open Orphan announced the launch of the 'hVIVO Covid Clear Test' on Thursday, its coronavirus antibody testing service, following the completion of installation, testing and training.
The AIM-traded firm said the antibody tests, which use the 'Quotient MosaiQ' system and 'MosaiQ Covid-19 Antibody Microarray', offered "best-in-class" Covid-19 antibody testing performance, and would require a full blood draw.

It said the hVIVO Covid Clear Test would be offered to large employer groups and channel partners including GP networks, nursing services, health clinics and private hospitals.

Samples would be tested in the Company's London laboratory, with results returned within 48 hours.

"hVIVO is a world class company with best in class scientists and facilities," said executive chairman Cathal Friel.

"We are very excited to be offering this service and I am confident our work will help large companies and clinics in the UK test their staff and patients to ensure the safety of all employees."

At 1221 BST, shares in Open Orphan were down 2.28% at 14.12p.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Hvivo Market Data

Currency UK Pounds
Share Price 28.50p
Change Today 0.60p
% Change 2.15 %
52 Week High 30.60p
52 Week Low 18.00p
Volume 1,724,303
Shares Issued 680.37m
Market Cap £193.91m

Hvivo Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
95.74% below the market average95.74% below the market average95.74% below the market average95.74% below the market average95.74% below the market average
65.71% below the sector average65.71% below the sector average65.71% below the sector average65.71% below the sector average65.71% below the sector average
Price Trend
78.19% above the market average78.19% above the market average78.19% above the market average78.19% above the market average78.19% above the market average
94.59% above the sector average94.59% above the sector average94.59% above the sector average94.59% above the sector average94.59% above the sector average
Income
94.38% below the market average94.38% below the market average94.38% below the market average94.38% below the market average94.38% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
Growth
52.34% above the market average52.34% above the market average52.34% above the market average52.34% above the market average52.34% above the market average
72.22% above the sector average72.22% above the sector average72.22% above the sector average72.22% above the sector average72.22% above the sector average

What The Brokers Say

Strong Buy 3
Buy 3
Neutral 0
Sell 0
Strong Sell 0
Total 6
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Hvivo Dividends

  Latest Previous
  Final Special
Ex-Div 18-Apr-24 04-May-23
Paid 20-May-24 09-Jun-23
Amount 0.20p 0.45p

Trades for 31-Oct-2024

Time Volume / Share Price
16:37 275 @ 28.50p
16:20 71,610 @ 28.25p
16:16 7,150 @ 28.40p
15:56 3,469 @ 28.65p
14:48 150,000 @ 28.15p

Hvivo Key Personnel

CEO Yamin Mo' Khan

Top of Page